// App-Quantinova.ai

P1266 : FLOW CYTOMETRY COMBINED WITH SYSTEMS BIOLOGY ENABLES RATIONAL TARGETING OF NFKB IN DLBCL

Researchers

Presenter

  • Eleanor Jayawant

Principal Investigators

  • Andrea Pepper

  • Chris Pepper

  • Simon Mitchell

Medical Centers

  • Brighton and Sussex Medical School,University of Sussex,Falmer, Brighton,Vereinigtes Königreich

  • Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom

  • Brighton and Sussex Medical School,University of Sussex,Falmer, Brighton,Royaume-uni

  • Brighton and Sussex Medical School,University

  • Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A